Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Recruiting

Phase 1

PF-07220060Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Sponsor:

Pfizer

Code:

NCT04557449

Conditions

Liposarcoma

Prostate Cancer

Breast Neoplasms

Adenocarcinoma of Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07220060

Letrozole

Fulvestrant

Midazolam

Enzalutamide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-10. This information was provided to ClinicalTrials.gov by Pfizer on 2025-02-05.